August 7, 2013 — According to the Southeast Texas Record, a woman from Daingerfield, Texas, has filed a lawsuit after she took Lipitor (atorvastatin) to lower cholesterol and developed type-2 diabetes.
The lawsuit alleges that Pfizer failed to adequately warn Ms. Henson and her physician about the risk of type-2 diabetes associated with Lipitor. She began taking Lipitor in 2006 and used it until she was diagnosed with diabetes in 2009. She is seeking compensation for her medical expenses, physical and emotional injuries, economic losses, punitive damages, and more.
Several lawsuits have been filed against Pfizer by people who took Lipitor and developed diabetes. Plaintiffs are now seeking to consolidate the lawsuits into a federal Multi-District Litigation (MDL), which would establish one court to centralize the growing nationwide litigation.
In 2012, the U.S. Food and Drug Administration (FDA) published a Drug Safety Communication to warn about studies linking Lipitor to a 9% increased risk of diabetes. They also warned, “People being treated with statins may have an increased risk of raised blood sugar levels and the development of Type 2 diabetes.” In February 2012, a study published in the Archives of Internal Medicine found that this risk may be 50% higher for post-menopausal women.